Would IgG be high or low 2 weeks after EBV (Epstein-Barr Virus) clinical symptoms onset?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

After 2 weeks of clinical symptoms of Epstein-Barr virus (EBV) infection, IgG antibodies would typically be high. This is because, as noted in the 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) 1, the presence of VCA IgM (with or without VCA IgG) antibodies in the absence of antibodies to EBNA indicates recent primary infection with EBV. Given that EBV has a long incubation period, by the time clinical symptoms appear, the body has already started to mount an immune response. Some key points to consider include:

  • The antibody response to EBV infection follows a predictable pattern, with IgM antibodies rising first and IgG antibodies beginning to rise shortly after and continuing to increase 1.
  • The presence of EBNA antibodies indicates infection more than 6 weeks from the time of the sample and therefore not likely implicating EBV as a cause 1.
  • Over 90% of the normal adult population has IgG class antibodies to VCA and EBNA antigens, although approximately 5%–10% of patients who have been infected with EBV fail to develop antibodies to the EBNA antigen 1. Considering these points, it is reasonable to expect IgG to be high after 2 weeks of clinical symptoms, as this timeframe allows for the immune system to have mounted a significant response to the infection, characterized by increasing levels of IgG antibodies.

From the Research

EBV Infection and IgG Levels

  • The incubation period of symptomatic primary EBV infection is approximately six weeks 2.
  • During this period, the immune response to EBV infection is not fully understood, but it is known that the virus can evade the host's immune surveillance through multiple mechanisms 3.
  • The diagnosis of acute EBV infection is often based on the combination of positive viral capsid antigen (VCA) IgM antibodies and negative EB viral nuclear antigen 1 (EBNA-1) IgG antibodies 4.

IgG Avidity and EBV Infection

  • Determination of EBV IgG avidity can help clarify the EBV status in patients with unclear serology 4, 5.
  • IgG avidity is typically low in the early stages of EBV infection and increases over time 4, 5.
  • In immunocompetent patients, low IgG avidity is often associated with acute primary infection, while high IgG avidity is associated with past infection 5.

Expected IgG Levels after 2 Weeks of Clinical Symptoms

  • Given that the incubation period of EBV infection is approximately six weeks, it is likely that IgG levels would still be increasing 2 weeks after the onset of clinical symptoms.
  • Studies have shown that IgG avidity is typically low in the early stages of EBV infection and increases over time 4, 5.
  • Therefore, it would be expected that IgG levels would be relatively low 2 weeks after the onset of clinical symptoms, but increasing as the infection progresses 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Primary Epstein-Barr virus infection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.